Hims & Hers Health Inc (NYSE: HIMS) is 30.44% higher on its value in year-to-date trading and has touched a low of $8.51 and a high of $35.02 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The HIMS stock was last observed hovering at around $30.51 in the last trading session, with the day’s gains setting it 1.03%.
Currently trading at $31.54, the stock is 14.16% and 12.24% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 7.66 million and changing 3.38% at the moment leaves the stock 52.48% off its SMA200. HIMS registered 246.97% gain for a year compared to 6-month gain of 44.88%. The firm has a 50-day simple moving average (SMA 50) of $28.0036 and a 200-day simple moving average (SMA200) of $20.59995.
The stock witnessed a 12.04% loss in the last 1 month and extending the period to 3 months gives it a 46.56%, and is 5.80% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.11% over the week and 7.58% over the month.
Hims & Hers Health Inc (HIMS) has around 1046 employees, a market worth around $6.89B and $1.24B in sales. Current P/E ratio is 72.96 and Fwd P/E is 60.49. Profit margin for the company is 8.15%. Distance from 52-week low is 270.84% and -9.94% from its 52-week high. The company has generated returns on investments over the last 12 months (22.52%).
with sales reaching $469.68M over the same period.The EPS is expected to grow by 592.48% this year, but quarterly earnings will post 67.63% year-over-year. Quarterly sales are estimated to grow 90.45% in year-over-year returns.
Hims & Hers Health Inc (HIMS) Top Institutional Holders
452.0 institutions hold shares in Hims & Hers Health Inc (HIMS), with institutional investors hold 72.75% of the company’s shares. The shares outstanding are 209.44M, and float is at 177.52M with Short Float at 31.87%. Institutions hold 64.43% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 16.47 million shares valued at $332.55 million. The investor’s holdings represent 7.7166% of the HIMS Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 14.57 million shares valued at $294.25 million to account for 6.8278 of the shares outstanding. The other top investors are RENAISSANCE TECHNOLOGIES LLC which holds 6.04 million shares representing 2.8294% and valued at over $121.94 million, while STATE STREET CORP holds 2.0709 of the shares totaling 4.42 million with a market value of $89.25 million.
Hims & Hers Health Inc (HIMS) Insider Activity
The most recent transaction is an insider sale by Chi Michael, the company’s Chief Commercial Officer. SEC filings show that Chi Michael sold 17,304 shares of the company’s common stock on Jan 24 ’25 at a price of $31.00 per share for a total of $0.54 million. Following the sale, the insider now owns 0.19 million shares.
Hims & Hers Health Inc disclosed in a document filed with the SEC on Jan 23 ’25 that Dudum Andrew (Chief Executive Officer) sold a total of 27,098 shares of the company’s common stock. The trade occurred on Jan 23 ’25 and was made at $30.08 per share for $0.82 million. Following the transaction, the insider now directly holds 27918.0 shares of the HIMS stock.
Still, SEC filings show that on Jan 24 ’25, Chi Michael (Officer) Proposed Sale 17,304 shares at an average price of $31.00 for $0.54 million. The insider now directly holds shares of Hims & Hers Health Inc (HIMS).
